Interplay of mineralocorticoid receptor antagonists and Empagliflozin in heart failure: Secondary analysis of the EMPEROR-Reduced trial.
13 Apr, 2022 | 10:14h | UTCEditorial: Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care